entertainment
Previous article:
Duchenne breakthrough therapy leaves behind pioneering families
Next article: AstraZeneca bets AAV gene therapy will still deliver the goods
Next article: AstraZeneca bets AAV gene therapy will still deliver the goods
leisure time
focus
-
Unicorn down: Following layoffs, Biofourmis CEO quietly departs
2025-09-06 01:52 -
Senate panel to vote on hospitals, PBMs, prisoner care
2025-09-06 01:51 -
Why Sanofi got shellacked over its spinoff
2025-09-06 01:51 -
Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
2025-09-06 00:15 -
WHO may add ‘noma' to its list of neglected tropical diseases
2025-09-05 23:46 -
First Opinion Podcast: How to protect health care in times of war
2025-09-05 23:21